Chung H. Kok

Adelaide, SA, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Editorial: Myelodysplastic neoplasm and acute myeloid leukemia: multi-omics approaches and precision medicine.

Editorial: Myelodysplastic neoplasm and acute myeloid leukemia: multi-omics approaches and precision medicine.

Journal: Frontiers in oncology

Published: April 20, 2026

CD47 stabilizes ROBO2 to regulate glioblastoma progression by preventing ITCH-mediated ubiquitination.

CD47 stabilizes ROBO2 to regulate glioblastoma progression by preventing ITCH-mediated ubiquitination.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 23, 2026

Mitochondrial DNA mutations are associated with impaired oxidative phosphorylation and enhanced imatinib response in chronic myeloid leukemia.

Mitochondrial DNA mutations are associated with impaired oxidative phosphorylation and enhanced imatinib response in chronic myeloid leukemia.

Journal: HemaSphere

Published: March 18, 2026

Direct measurement of in vivo BCR::ABL1 kinase inhibition reveals stronger potency of asciminib as compared with imatinib and nilotinib.

Direct measurement of in vivo BCR::ABL1 kinase inhibition reveals stronger potency of asciminib as compared with imatinib and nilotinib.

Journal: Leukemia

Published: March 10, 2026

Infection risk in myelodysplastic syndromes is dynamic and immune driven.

Infection risk in myelodysplastic syndromes is dynamic and immune driven.

Journal: Blood advances

Published: January 27, 2026

Caspase-2 deficiency drives pathogenic liver polyploidy and increases age-associated hepatocellular carcinoma in mice.

Caspase-2 deficiency drives pathogenic liver polyploidy and increases age-associated hepatocellular carcinoma in mice.

Journal: Science advances

Published: January 01, 2026

Shaping the future of multiple myeloma with artificial intelligence and digital twins: from concept to clinic.

Shaping the future of multiple myeloma with artificial intelligence and digital twins: from concept to clinic.

Journal: Frontiers in digital health

Published: December 19, 2025

Evaluating NGS variant callers in a challenging genomic context with a focus on the PRSS1-PRSS2 locus for hereditary pancreatitis.

Evaluating NGS variant callers in a challenging genomic context with a focus on the PRSS1-PRSS2 locus for hereditary pancreatitis.

Journal: Gut

Published: September 21, 2025

Elevated desmoglein-2 expression in multiple myeloma is a prognostic marker across genomic subtypes with impact on high-risk cytogenetics and a distinct gene expression profile.

Elevated desmoglein-2 expression in multiple myeloma is a prognostic marker across genomic subtypes with impact on high-risk cytogenetics and a distinct gene expression profile.

Journal: British journal of haematology

Published: September 02, 2025

Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations.

Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations.

Journal: Blood

Published: June 06, 2025

RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm.

RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm.

Journal: Blood advances

Published: March 05, 2025

Enhanced Detection of Splice-Altering Variants in Hematologic Malignancies Using Targeted RNA-Sequencing Data.

Enhanced Detection of Splice-Altering Variants in Hematologic Malignancies Using Targeted RNA-Sequencing Data.

Journal: The Journal of molecular diagnostics : JMD

Published: February 25, 2025

Showing 1-12 of 75

Last Updated: 09/26/2026